Literature DB >> 19595629

Changes of cortical excitability after dopaminergic treatment in restless legs syndrome.

Anna Scalise1, Italo Pittaro-Cadore, Francesco Janes, Roberto Marinig, Gian Luigi Gigli.   

Abstract

OBJECTIVE: Dopaminergic pathways are most likely involved in the pathophysiology of restless legs syndrome (RLS). In previous investigations, an alteration of cortical excitability was suggested to be related to a dopaminergic dysfunction in RLS. The purpose of our study was to compare practice-dependent plasticity in RLS patients before and after a month of dopaminergic treatment.
METHODS: Single-pulse transcranial magnetic stimulation (TMS) was used to define motor evoked potential (MEP) amplitude, motor threshold, and silent period (SP) as well. Subjects performed three exercise blocks (bimanual motor task). MEP amplitude, registered immediately after each exercise block and after a rest period, was compared to baseline. The time course of intra-cortical inhibition was tested using paired-pulse TMS at short inter-stimulus intervals. For the single-pulse TMS procedures, we enrolled 12 patients affected by primary RLS and 12 normal subjects. For the paired-pulse TMS procedures, only six patients underwent the examination. RLS patients underwent the examination in both pre- and post-dopaminergic treatment conditions.
RESULTS: In RLS patients MEP amplitude increased after the rest period only in the post-treatment condition, showing a delayed facilitation. After exercise, MEP amplitude increased, but not enough to be significant, showing a positive trend but not a clear-cut post-exercise facilitation. In the pre-treatment condition instead, MEP amplitude did not change either after rest period or after exercise. RLS patients showed a marked increase of the central motor inhibition, assessed by using paired-pulse TMS at short inter-stimulus intervals after pramipexole treatment. On the contrary, the duration of the SP did not change compared to the pre-treatment condition.
CONCLUSIONS: In RLS patients after dopaminergic treatment, the main finding was the changing of MEP amplitude after rest following a motor task. Since dopaminergic treatment can reverse delayed facilitation in RLS, we hypothesized that cortical plasticity related to dopaminergic systems may play a crucial role in RLS pathophysiology. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19595629     DOI: 10.1016/j.sleep.2009.05.003

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  13 in total

1.  Darwin's Predisposition and the Restlessness that Drives Sleepwalking.

Authors:  Michael Howell
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

2.  Circadian Change in Blink Reflex Recovery in Restless Legs Syndrome.

Authors:  Nurten Uzun; Ayşegül Gündüz; Derya Karadeniz; Meral E Kiziltan
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

3.  Impairment of sensory-motor integration in patients affected by RLS.

Authors:  Vincenzo Rizzo; I Aricò; G Liotta; L Ricciardi; C Mastroeni; F Morgante; R Allegra; R Condurso; P Girlanda; R Silvestri; A Quartarone
Journal:  J Neurol       Date:  2010-07-16       Impact factor: 4.849

Review 4.  Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.

Authors:  Richard P Allen
Journal:  Sleep Med Clin       Date:  2015-07-15

Review 5.  Treatment of restless legs syndrome.

Authors:  Cynthia L Comella
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

6.  Increased electroencephalographic high frequencies during the sleep onset period in patients with restless legs syndrome.

Authors:  Raffaele Ferri; Filomena I I Cosentino; Mauro Manconi; Francesco Rundo; Oliviero Bruni; Marco Zucconi
Journal:  Sleep       Date:  2014-08-01       Impact factor: 5.849

7.  Auditory and Lower Limb Tactile Prepulse Inhibition in Primary Restless Legs Syndrome: Clues to Its Pathophysiology.

Authors:  Fidias E Leon-Sarmiento; Elizabeth Peckham; Daniel S Leon-Ariza; William Bara-Jimenez; Mark Hallett
Journal:  J Clin Neurophysiol       Date:  2015-08       Impact factor: 2.177

8.  The role of BTBD9 in the cerebral cortex and the pathogenesis of restless legs syndrome.

Authors:  Shangru Lyu; Hong Xing; Mark P DeAndrade; Pablo D Perez; Keer Zhang; Yuning Liu; Fumiaki Yokoi; Marcelo Febo; Yuqing Li
Journal:  Exp Neurol       Date:  2019-11-09       Impact factor: 5.330

9.  Effects of a 12-week yoga versus a 12-week educational film intervention on symptoms of restless legs syndrome and related outcomes: an exploratory randomized controlled trial.

Authors:  Kim E Innes; Terry Kit Selfe; Caitlin Montgomery; Nicole Hollingshead; Zenzi Huysmans; Roshini Srinivasan; Sijin Wen; Madeleine J Hausmann; Karen Sherman; Maryanna Klatt
Journal:  J Clin Sleep Med       Date:  2020-01-15       Impact factor: 4.062

10.  Recurrent CSPs after Transcranial Magnetic Stimulation of Motor Cortex in Restless Legs Syndrome.

Authors:  Aulikki Ahlgrén-Rimpiläinen; Hannu Lauerma; Seppo Kähkönen; Juha Markkula; Ilpo Rimpiläinen
Journal:  Neurol Res Int       Date:  2012-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.